Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited peer ...

Why AtaiBeckley (ATAI) is on investors’ radar today AtaiBeckley (ATAI) has attracted fresh attention after a period of mixed share performance, including a roughly 2% move lower over the past day and ...

AtaiBeckley Inc. (NASDAQ:ATAI) secured a spot on our list of the best penny stocks set to explode. AtaiBeckley Inc.

AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best multibagger penny stocks to invest in. On March 27, Deutsche Bank initiated ...

That drug, tagged BPL-003 by Atai, is an antidepressant that was recently evaluated in an open-label phase 2a study. The company is developing the medication in collaboration with a privately held ...

Shares of atai Life Sciences (NASDAQ:ATAI) traded higher in the premarket on Tuesday after the company and its partner, Beckley Psytech Limited, said their jointly developed psychedelic drug BPL-003 ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is atai Life Sciences N.V. (ATAI) one of those stocks right now? By taking a look at ...

We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are going to take a look at where Atai Life Sciences N.V. (NASDAQ:ATAI) stands ...

The biotech earned an important fast-track review designation from a major regulator. This should speed the development (and potentially, commercialization) of one of its investigational treatments.